APA (7th ed.) Citation

GR, D., L, D., JJ, B., DP, L., V, A., SD, B., . . . JW, E. (2021). Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease. Heart (British Cardiac Society), 107(14), 1130. https://doi.org/10.1136/heartjnl-2020-318758

Chicago Style (17th ed.) Citation

GR, Dagenais, et al. "Cardiovascular Consequences of Discontinuing Low-dose Rivaroxaban in People with Chronic Coronary or Peripheral Artery Disease." Heart (British Cardiac Society) 107, no. 14 (2021): 1130. https://doi.org/10.1136/heartjnl-2020-318758.

MLA (9th ed.) Citation

GR, Dagenais, et al. "Cardiovascular Consequences of Discontinuing Low-dose Rivaroxaban in People with Chronic Coronary or Peripheral Artery Disease." Heart (British Cardiac Society), vol. 107, no. 14, 2021, p. 1130, https://doi.org/10.1136/heartjnl-2020-318758.